查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786721

全球水凝胶药物传输系统市场

Hydrogel-based Drug Delivery Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 290 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球水凝胶药物传输系统市场规模将达到 216 亿美元

全球水凝胶药物输送系统市场规模预计在2024年为153亿美元，预计到2030年将达到216亿美元，2024年至2030年的复合年增长率为5.9%。本报告分析的细分市场之一—天然水凝胶，预计其复合年增长率为6.1%，到分析期结束时将达到123亿美元。合成水凝胶细分市场在分析期间的复合年增长率预计为5.9%。

美国市场规模估计为 42 亿美元，中国市场预期复合年增长率为 9.3%

预计到2024年，美国水凝胶药物传输系统市场规模将达42亿美元。作为世界第二大经济体的中国，预计2030年市场规模将达到44亿美元，在2024-2030年的分析期间内，复合年增长率为9.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.9%和5.8%。在欧洲，预计德国市场的复合年增长率为3.8%。

全球水凝胶药物传输系统市场－主要趋势与驱动因素摘要

为什么基于水凝胶的系统会改变现代药物传递？

基于水凝胶的药物传输系统已成为精准医疗发展的基石，为可控的标靶治疗输送提供了先进的平台。这些亲水性聚合物网络因其生物相容性、高含水量和可调节的物理特性而备受推崇，这些特性可以模拟自然组织环境。它们的关键区别在于能够响应各种生理刺激，例如 pH 值、温度和酶，从而实现位点特异性药物释放并增强治疗效果。近年来，智慧水凝胶和奈米复合水凝胶等新型水凝胶配方已被设计用于提高药物的保留和反应能力，尤其是在肿瘤学、眼部科学和伤口护理应用中。这个创新主导的领域正在重塑治疗模式，提供个人化、微创和高效的治疗选择。

创新是生物医学应用激增的催化剂吗？

水凝胶除了用于药物传输外，还广泛效用各种医疗领域，提升了其在医疗保健领域的战略价值。它们在组织工程支架、再生医学、诊断系统等领域的应用凸显了其多功能性。尤其是可注射水凝胶，它透过最大限度地减少全身暴露并提供局部持续的药物输送，彻底改变了术后恢復和慢性病管理。这项进步在癌症治疗中尤其明显，水凝胶有助于将化疗药物直接输送到肿瘤部位并降低毒性。此外，水凝胶技术与生物电子设备的结合实现了即时治疗回馈系统，弥合了个人化医疗中诊断与治疗之间的差距。这些跨学科应用正在推动水凝胶技术成为医学创新的主流。

监管和研究生态系统如何影响市场轨迹？

支持性监管途径和强有力的研究倡议正在显着加速基于水凝胶的药物递送系统的商业性潜力。在全球范围内，政府和学术界正在增加研发投资，以改进水凝胶配方并探索其与生技药品、胜肽和基因疗法的协同应用。 FDA 对生物材料核准的灵活方式进一步新兴企业以更短的前置作业时间将新型水凝胶系统推向市场铺平了道路。此外，该领域的专利活动正在增加，临床研究中有大量基于水凝胶的治疗方法。同时，产学研创新生态系统正在兴起，尤其是在北美和亚太地区，使这些地区成为先进水凝胶技术开发的热点。这些因素不仅丰富了产品平臺，而且还透过流程优化和可扩展性推动成本降低。

为什么多个治疗领域的市场扩张正在加速？

水凝胶基药物传输系统市场的成长受到多种因素的驱动，反映了技术进步、使用案例的扩大和消费者期望的变化。以患者为中心的非侵入性治疗方法的需求日益增长，这与水凝胶在局部和持续给药方面的能力一致。水凝胶基质的 3D 列印和微流体辅助药物封装等技术改进使生产更加高效和可客製化。肿瘤学、整形外科和皮肤病学等终端用户领域由于其精确性和适应性，越来越多地采用水凝胶基治疗方法。此外，人口老化和慢性病的流行正在推动对长效注射系统和植入式输送装置的需求。从消费行为的角度来看，对个人化、易于使用的药物传输解决方案的偏好日益增加，进一步推动了市场需求。拉丁美洲和东南亚新兴市场医疗保健支出的增加也在推动水凝胶技术的市场渗透。

部分

聚合物来源（天然、合成、混合）、给药途径（皮下、眼部、口服、局部、其他）

受访公司范例

  • 3M Company
  • AD Surgical
  • Aquestive Therapeutics Inc.
  • ARx LLC
  • Ashland
  • AstraZeneca Plc.
  • Bausch & Lomb
  • BioDelivery Sciences International Inc.
  • Blairex Laboratories Inc.
  • Coloplast A/S
  • Ferring BV
  • Johnson & Johnson
  • Medtronic
  • Micropore Technologies
  • Neurelis, Inc.
  • Ocular Therapeutix, Inc.
  • Pfizer, Inc.
  • ProLynx Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP31492

Global Hydrogel-based Drug Delivery Systems Market to Reach US$21.6 Billion by 2030

The global market for Hydrogel-based Drug Delivery Systems estimated at US$15.3 Billion in the year 2024, is expected to reach US$21.6 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Natural, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the Synthetic segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 9.3% CAGR

The Hydrogel-based Drug Delivery Systems market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Hydrogel-Based Drug Delivery Systems Market - Key Trends & Drivers Summarized

What Makes Hydrogel-Based Systems a Game-Changer in Modern Drug Delivery?

Hydrogel-based drug delivery systems have emerged as a cornerstone in the evolution of precision medicine, offering an advanced platform for controlled and targeted therapeutic delivery. These hydrophilic polymer networks are prized for their biocompatibility, high water content, and tunable physical properties, which mimic natural tissue environments. A key differentiator lies in their capacity to respond to various physiological stimuli-such as pH, temperature, and enzymes-allowing for site-specific drug release and enhanced therapeutic efficacy. Over recent years, novel hydrogel formulations such as smart hydrogels and nanocomposite hydrogels have been engineered to improve drug retention time and responsiveness, especially in oncological, ophthalmic, and wound care applications. This innovation-driven sector is reshaping treatment paradigms, offering personalized, minimally invasive, and efficient therapeutic options.

Is Innovation the Catalyst Behind the Surge in Biomedical Applications?

Hydrogels have found extensive utility across a wide spectrum of medical applications beyond drug delivery, reinforcing their strategic value in the healthcare sector. Their use in tissue engineering scaffolds, regenerative medicine, and diagnostic systems highlights their versatility. In particular, injectable hydrogels are revolutionizing post-surgical recovery and chronic disease management by providing localized, sustained drug delivery with minimal systemic exposure. This advancement is notably evident in cancer therapeutics, where hydrogels facilitate the direct delivery of chemotherapeutic agents to tumor sites, reducing toxicity. Additionally, the integration of hydrogel technologies with bioelectronic devices is enabling real-time therapeutic feedback systems, creating a bridge between diagnostics and therapy in personalized medicine. Such cross-disciplinary applications are pushing hydrogel technologies into the mainstream of medical innovation.

How Are Regulatory and Research Ecosystems Shaping Market Trajectories?

Supportive regulatory pathways and robust research initiatives are significantly accelerating the commercial viability of hydrogel-based drug delivery systems. Governments and academic institutions globally are increasingly investing in R&D to improve hydrogel formulations and explore their synergistic use with biologics, peptides, and gene therapies. The FDA’s flexible stance on biomaterial approvals has further paved the way for startups and pharma giants alike to bring novel hydrogel systems to market with reduced lead times. Moreover, patent activity in this domain is on the rise, with a strong pipeline of hydrogel-enabled therapeutics under clinical investigation. In parallel, academic-industry collaborations are fostering innovation ecosystems, particularly in North America and Asia-Pacific, which are becoming hotspots for advanced hydrogel technology development. These factors are not only enhancing product pipelines but are also driving down costs through process optimization and scalability.

Why Is Market Expansion Accelerating Across Multiple Therapeutic Frontiers?

The growth in the hydrogel-based drug delivery systems market is driven by several factors that reflect a convergence of technological advances, expanding end-use cases, and shifting consumer expectations. The rising demand for patient-centric, non-invasive treatment modalities is aligning with hydrogel capabilities in localized and sustained drug administration. Technological improvements such as 3D printing of hydrogel matrices and microfluidic-assisted drug encapsulation are making production more efficient and customizable. End-user sectors like oncology, orthopedics, and dermatology are increasingly adopting hydrogel-based therapies due to their precision and adaptability. Additionally, aging populations and the prevalence of chronic diseases are increasing the demand for long-acting injectable systems and implantable delivery devices. From a consumer behavior standpoint, there is a growing preference for personalized, easy-to-use drug delivery solutions, further propelling market demand. Emerging markets in Latin America and Southeast Asia are also witnessing a rise in healthcare spending, enabling broader market penetration of hydrogel technologies.

SCOPE OF STUDY:

The report analyzes the Hydrogel-based Drug Delivery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Polymer Origin (Natural, Synthetic, Hybrid); Administration Route (Subcutaneous, Ocular, Oral Cavity, Topical, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • 3M Company
  • AD Surgical
  • Aquestive Therapeutics Inc.
  • ARx LLC
  • Ashland
  • AstraZeneca Plc.
  • Bausch & Lomb
  • BioDelivery Sciences International Inc.
  • Blairex Laboratories Inc.
  • Coloplast A/S
  • Ferring B.V.
  • Johnson & Johnson
  • Medtronic
  • Micropore Technologies
  • Neurelis, Inc.
  • Ocular Therapeutix, Inc.
  • Pfizer, Inc.
  • ProLynx Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Hydrogel-based Drug Delivery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surging Demand for Targeted and Controlled Drug Delivery Spurs Growth in Hydrogel-based Systems
    • Growing Prevalence of Chronic Diseases Strengthens Business Case for Long-Acting Drug Delivery Platforms
    • Advancements in Biocompatible Materials Expand Addressable Market Opportunity for Hydrogel-based Formulations
    • Increasing R&D Investment by Pharmaceutical Companies Drives Innovation in Hydrogel-based Therapeutics
    • Rising Adoption of Personalized Medicine Accelerates Demand for Tunable Hydrogel Carriers
    • Expansion of Biologics and Peptide Drug Pipeline Spurs Interest in Hydrogel Delivery Technologies
    • Growing Popularity of Minimally Invasive Therapies Drives Adoption of Injectable Hydrogel Systems
    • Supportive Regulatory Approvals and Fast-Track Designations Sustain Growth Momentum Across Developed Markets
    • Proliferation of 3D Printing in Biomedical Applications Throws the Spotlight on Smart Hydrogels for On-Demand Drug Release
    • Escalating Focus on Patient Compliance and Convenience Generates Demand for Sustained Release Hydrogel Platforms
    • Rising Interest in Nanotechnology Integration Propels Development of Advanced Hydrogel Drug Carriers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hydrogel-based Drug Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Natural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Natural by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Natural by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Subcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ocular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ocular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oral Cavity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oral Cavity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Oral Cavity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Hydrogel-based Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hydrogel-based Drug Delivery Systems by Polymer Origin - Natural, Synthetic and Hybrid Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Polymer Origin - Percentage Breakdown of Value Sales for Natural, Synthetic and Hybrid for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hydrogel-based Drug Delivery Systems by Administration Route - Subcutaneous, Ocular, Oral Cavity, Topical and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Hydrogel-based Drug Delivery Systems by Administration Route - Percentage Breakdown of Value Sales for Subcutaneous, Ocular, Oral Cavity, Topical and Others for the Years 2015, 2025 & 2030

IV. COMPETITION